Medical Genetics seminars
May 2022
Mitochondrial leukodystrophies
Anna Ardissone· Institute of Neurology Carlo Besta, Milan, Italy
Recorded
January 2022
ASO RNA splice modulating therapies for genetic brain disorders
Willeke van Roon-Mom· University of Leiden, the Netherlands
Recorded
October 2021
X-linked adrenoleukodystrophies - Update
Caroline Sevin· Reference Center for Leukodystrophies, Hospital Bicêtre and Institute for Brain and Spine, Paris, France
Recorded
August 2021
Interpretation of SYNGAP1 Variants
Eduardo Perez Palma, PhD· Universidad del Desarrollo, Santiago (Chile)
Thu, Aug 19 · 01:00 UTC · Online
April 2021
Modulating gene regulation to treat gene dosage-associated diseases
Nadav Ahituv, PhD· University of California
Thu, Apr 1 · 01:00 UTC · Online
February 2021
Genome architecture and disease: the 16p11.2 paradigm
Alexandre Reymond· Center for Integrative Genomics, University of Lausanne, Switzerland
Thu, Feb 18 · 12:15 UTC · Online
Lysosomal storage disorders and their unanticipated links to rare and common diseases
Frances Platt· University of Oxford
Mon, Feb 8 · 11:00 UTC · Online
Lysosomal storage diseases are a group of over 70 inherited metabolic disorders, many of which have a neurodegenerative clinical course. Treatments have been developed for a subset of these disorders and are now in routine clinical use. We have found that some neurological and neurodegenerative diseases share unanticipated links to lysosomal storage diseases providing insights into disease pathogenesis. These links also suggest treatments developed for lysosomal disorders may have unanticipated utility in other rare and common diseases.
End of results.